(MENAFN- EIN Presswire) EINPresswire/ --
Explore the booming Veterinary Eye Care Market, projected to grow from USD 7.43 Bn in 2024 to USD 11.40 Bn by 2032 at a 5.5% CAGR. Discover trends, growth drivers, AI diagnostics, tele-ophthalmology, minimally invasive treatments, and key insights shaping the global pet eye care industry.

Veterinary Eye Care Market Overview:

Veterinary Eye Care Market is projected to rise from USD 7.43 Bn in 2024 to USD 11.40 Bn by 2032, fueled by increasing pet ocular disorders, growing awareness of preventive eye health, and demand for AI diagnostics, tele-ophthalmology, minimally invasive surgeries, and topical therapies. Key players like Zoetis, Bausch + Lomb, and Dechra Pharmaceuticals drive innovation, while North America leads and Europe and Asia Pacific present strong growth potential.

Veterinary Eye Care Market Set to Soar as Advanced Ophthalmology and Telemedicine Revolutionize Pet Eye Health

Veterinary Eye Care Market is surging as 20-30% of pets, including dogs and cats, face cataracts, glaucoma, conjunctivitis, and corneal ulcers, driving demand for preventive and advanced treatments. Breakthroughs in veterinary ophthalmology, from OCT imaging and digital slit-lamp diagnostics to phacoemulsification surgeries and anti-inflammatory eye drops, along with tele-ophthalmology, are making expert pet eye care faster, more accessible, and highly effective, fuelling unprecedented growth in the U.S. and global markets.

Veterinary Eye Care Market Unlocks New Growth as AI, Tele-ophthalmology, and Advanced Treatments Transform Pet Health

Veterinary Eye Care Market offers untapped opportunities as rising pet ownership, growing awareness of ocular health, and demand for advanced diagnostics and minimally invasive treatments create a surge in preventive and therapeutic eye care solutions. Emerging trends in tele-ophthalmology, AI-assisted imaging, and veterinary-specific pharmaceuticals are transforming how dogs, cats, and other companion animals receive care, opening exciting growth avenues across the U.S. and global veterinary eye care market.

👉 Access the full Research Description at:

Veterinary Eye Care Market Confronts High-Cost Hurdles:

Can Tele-ophthalmology and Pet Insurance Unlock Growth?

Veterinary Eye Care Market faces cost-driven challenges as advanced ophthalmic treatments like phacoemulsification for canine cataracts cost USD 2,000–4,000 per eye, while diagnostic tools such as tonometers and OCT systems require hospitals to invest USD 15,000–40,000. These financial barriers risk limiting access and slowing growth, but expanding pet insurance coverage and affordable tele-ophthalmology solutions offer practical ways to improve accessibility and sustain momentum in the U.S. and global veterinary eye care market.

Veterinary Eye Care Market Booms:

Canine Treatments, Conjunctivitis, and Topical Therapies Driving Explosive Growth

Veterinary Eye Care Market is witnessing rapid growth across diagnosis, treatment, and specialized care. The treatment segment, covering medications, lenses, and laser devices, dominates with over 56% of the market, reflecting the rising prevalence of ocular conditions in pets. Among animals, canines lead the market, with millions of U.S. households seeking specialized eye care for conditions like cataracts, glaucoma, corneal ulcers, and retinal diseases. Topical treatments, including NSAIDs, lubricants, corticosteroids, and antibiotics, remain the preferred route due to ease of use and rapid therapeutic effect, while conjunctivitis emerges as the most common indication, driving high demand.

Key Trends in Veterinary Eye Care Market:

AI Diagnostics, Tele-Ophthalmology & Minimally Invasive Surgery Driving Growth

Technological Advancements: Integration of AI diagnostics, tele-ophthalmology, and advanced surgical tools is enhancing accuracy, efficiency, and accessibility in the veterinary eye care market.

Minimally Invasive Surgery: Rising demand for phacoemulsification systems and glaucoma implants is driving better outcomes and faster recovery in the veterinary eye care market.

Veterinary Eye Care Market Key Developments:

Zoetis and Dechra Drive Innovation with Advanced Ophthalmic Treatments

Zoetis R&D Initiatives: In 2024, Zoetis launched new programs for sustained-release ophthalmic treatments, advancing management of chronic eye conditions in companion animals.

Dechra Pharmaceuticals Initiatives: In 2024, Dechra expanded veterinary ophthalmology investments with advanced NSAID and corticosteroid formulations for animal eye care.

👉 Access the full Research Description at:

North America Veterinary Eye Care Market Leads Globally:

Advanced Infrastructure and High Pet Ownership Drive Ophthalmic Innovations

North America Veterinary Eye Care Market leads globally, driven by advanced veterinary infrastructure, high pet ownership, and cutting-edge animal health care. With over 70,000 U.S. veterinarians and nearly 70% of households owning pets, demand for specialized ophthalmic diagnostics and treatments is soaring. Investments in integrated electronic health records (EHRs) enable precise tracking and management of chronic eye disorders, positioning the region as a hub for innovative veterinary eye care solutions.

Veterinary Eye Care Market Leaders Zoetis & Bausch + Lomb Drive Innovation with Advanced Ophthalmic Therapies

Veterinary Eye Care Market is dominated by Zoetis Inc. and Bausch + Lomb, leading with veterinary-specific innovations, advanced ophthalmic therapies, and global distribution networks. Zoetis drives growth with a robust drug portfolio for pet eye infections and inflammation, while Bausch + Lomb leverages its human ophthalmology expertise to deliver precision eye care solutions. Recent developments, including Bausch & Lomb's Project Watson for canine eye and ear health (2022) and Merck Animal Health's acquisition of EyeBio (2024), highlight a surge in advanced veterinary ophthalmic treatments, fuelling market expansion and innovation worldwide.

Veterinary Eye Care Market Key Player:

North America

Zoetis (USA)
Bausch + Lomb (Canada)
Merck Animal Health (USA)
Innovacyn (USA)
I-MED Animal Health (Canada)
Accutome (USA)
LKC Technologies (USA)
TVM Animal Health (UK)
Bayer Animal Health (USA)
Manna Pro Products (USA)

Europe

Dechra Pharmaceuticals (UK)
Ceva Santé Animale (France)
Halma (Keeler, UK)
HEINE Optotechnik (Germany)
AJL Ophthalmic (Spain)
AN-VISION GmbH (Germany)
Revenio Group (iCare) (Finland)
Optomed (Finland)
Domes Pharma (France)
Anicura (Sweden)

Asia Pacific

NIDEK (Japan)
Menicon (Japan)
Nova Eye Medical (Australia)
Yuesen Med (China)
Icare Finland Oy (Finland)
Freedom Ophthalmic (India)

Middle East and Africa

CorNeat Vision (Israel)
Beaphar (Netherlands)

South America

Agener União Saúde Animal (Brazil)
Ourofino Saúde Animal (Brazil)

Analyst Perspective:

Veterinary Eye Care Market is poised for robust growth, driven by rising ocular disorders in pets, including cataracts, glaucoma, conjunctivitis, and corneal complications affecting 20–30% of animals globally. Increasing pet ownership, especially in North America and Europe, combined with growing awareness of preventive and advanced eye care, is boosting demand for specialized diagnostics, AI-assisted imaging, tele-ophthalmology, and minimally invasive surgeries like phacoemulsification and glaucoma implants. Topical therapies and advanced veterinary pharmaceuticals from key players like Zoetis and Dechra Pharmaceuticals enhance treatment efficacy and market penetration. North America leads with advanced infrastructure and high pet adoption, while Europe and Asia Pacific present strong growth potential.

FAQ

Q1: What is the expected growth of the Veterinary Eye Care Market?
A1: The global Veterinary Eye Care Market is projected to grow from USD 7.43 Bn in 2024 to USD 11.40 Bn by 2032 at a 5.5% CAGR.

Q2: Which pets are most affected and drive market demand?
A2: Dogs and cats, with 20–30% experiencing cataracts, glaucoma, conjunctivitis, and corneal complications, drive the highest demand.

Q3: What are the key trends shaping veterinary eye care?
A3: AI diagnostics, tele-ophthalmology, minimally invasive surgeries, and topical therapies are transforming pet eye care globally.

Maximize Market Research is launching a subscription model for data and analysis in the
Dental Materials market

Related Reports:

Medical Image Analysis Software Market:

Radiotherapy Market:

Paronychia Treatment Market:

Ophthalmic Disease Therapeutics Market:

Vulvar Cancer Market:

About Stellar Market Research:

Stellar Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

MENAFN17102025003118003196ID1110210278